Sellas Life Sciences
SLS
$1.35
Share price
5.47%
Change (1 day)
-8.16%
Change (1 year)
Categories
Sellas Life Sciences (SLS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $14.19 M
According to Sellas Life Sciences's latest financial reports the company's total liabilities are $14.19 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sellas Life Sciences - Total liabilities on balance sheet (from 2006 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $16.09 M | 171.46% |
| 2021-12-31 | $5.92 M | -67.23% |
| 2020-12-31 | $18.08 M | 72% |
| 2019-12-31 | $10.51 M | -9.89% |
| 2018-12-31 | $11.67 M | -62.9% |
| 2017-12-31 | $31.45 M | 175.52% |
| 2016-12-31 | $11.41 M | -83.36% |
| 2015-12-31 | $68.63 M | 58.03% |
| 2014-12-31 | $43.42 M | -47.1% |
| 2013-12-31 | $82.09 M | 201.47% |
| 2012-12-31 | $27.23 M | 30.56% |
| 2011-12-31 | $20.85 M | 313.32% |
| 2010-12-31 | $5.04 M | -8.44% |
| 2009-12-31 | $5.51 M | 296.19% |
| 2008-12-31 | $1.39 M | 5.06% |
| 2007-12-31 | $1.32 M | |
| 2006-12-31 | $N/A |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 96.68% | 🇺🇸 USA |